The cellular basis of the efficacy of the trinuclear platinum complex BBR 3464 against cisplatin-resistant cells

Journal of Inorganic Biochemistry

Volumn 77, Issue 1-2, 1999, Pages 59-64

  Perego, Paola ^a   Gatti, Laura ^a   Caserini, Claudia ^a   Supino, Rosanna ^a   Colangelo, Donato ^b   Leone, Roberto ^c   Spinelli, Silvano ^d   Farrell, Nicholas ^e   Zunino, Franco ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

^d Boehringer Ingelheim Italia SpA   (Italy)

^e VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

BBR 3464; Cisplatin resistance

Indexed keywords

BBR 3464; CISPLATIN DERIVATIVE;

ARTICLE; CONTROLLED STUDY; CROSS LINKING; DRUG CYTOTOXICITY; DRUG DNA BINDING; DRUG EFFICACY; DRUG POTENCY; HUMAN; HUMAN CELL; OSTEOSARCOMA; PROTEIN EXPRESSION;

ADENOSINE TRIPHOSPHATASES; ANTINEOPLASTIC AGENTS; BASE PAIR MISMATCH; BONE NEOPLASMS; CARCINOMA; CARRIER PROTEINS; CISPLATIN; COLONIC NEOPLASMS; CROSS-LINKING REAGENTS; DNA POLYMERASE BETA; DNA REPAIR; DNA REPAIR ENZYMES; DNA, NEOPLASM; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MUTS HOMOLOG 2 PROTEIN; NEOPLASM PROTEINS; NUCLEAR PROTEINS; ORGANOPLATINUM COMPOUNDS; OSTEOSARCOMA; PLATINUM; PROTEINS; PROTO-ONCOGENE PROTEINS; TUMOR CELLS, CULTURED;

EID: 0033396192     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-0134(99)00142-7     Document Type: Article

References (13)

1. Brabec V., Kaspàrkovà J, Vràna O., Novàkovà O., Cox J., Qu Y., Farrell N. Biochemistry. 38:1999;6781-6790.
2. Pratesi G., Perego P., Polizzi D., Righetti S.C., Supino R., Caserini C., Manzotti C., Giuliani F.C., Pezzoni G., Tognella S., Spinelli S., Farrell N., Zunino F. Br. J. Cancer. 80:1999;1912-1919.
3. Farrell N., Qu Y., Kaspàrkovà J., Brabec V., Valsecchi M., Menta E., Di Domenico R., Conti M., Da Re G., Lotto A., Spinelli S. Proc. Am. Ass. Cancer Res. 38:1997;310.
4. Bonetti A., Apostoli P., Zanninelli M., Pavanel F., Colombatti M., Cetto G.L., Franceschi T., Sperotto L., Leone R. Clin. Cancer Res. 2:1996;1829-1835.
5. Kohn K.W. Methods Cancer Res. 16:1979;291-298.
6. K.W. Kohn, R.A.G. Ewig, L.C. Erickson, L.A. Zwelling, in: E.C. Friedberg, P.C. Hanawalt (Eds.), DNA Repair. A Laboratory Manual of Research Procedures, vol. 1, part B, Marcel Dekker, New York, 1981, pp. 370-401.
7. Perego P., Capranico G., Supino R., Zunino F. Anti-Cancer Drugs. 5:1994;645-649.
8. Perego P., Giarola M., Righetti S.C., Supino R., Caserini C., Delia D., Pierotti M.A., Miyashita T., Reed J.C., Zunino F. Cancer Res. 56:1996;556-562.
9. Aebi S., Kurdi-Haidar B., Gordon R., Cenni B., Zheng H., Fink D., Christen R.D., Boland C.R., Koi M., Fishel R., Howell S.B. Cancer Res. 56:1996;3087-3090.
10. Gately D.P., Howell S.B. Br. J. Cancer. 67:1993;1171-1176.
11. Wang T.S.F. Annu. Rev. Biochem. 60:1991;513-552.
12. Anthoney D.A., McIlwrath A.J., Gallagher W.M., Edlin A.R.M., Brown R. Cancer Res. 56:1996;1374-1381.
13. Kolodner R.D., Marsischky G.T. Curr. Opin. Genet. Dev. 9:1999;89-96.